The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2023

Filed:

Mar. 31, 2022
Applicants:

Asavi Llc, Hallandale, FL (US);

Alexandre Vasilievich Ivachtchenko, Hallandale, FL (US);

Alena Alexandrovna Ivachtchenko, Hallandale, FL (US);

Nikolay Filippovich Savchuk, Rancho Santa Fe, CA (US);

Inventors:

Alexandre Vasilievich Ivachtchenko, Hallandale, FL (US);

Andrey Alexandrovich Ivashchenko, Moscow, RU;

Alena Alexandrovna Ivachtchenko, Hallandale, FL (US);

Ilya Andreevich Ivachtchenko, Moscow region, RU;

Nikolay Filippovich Savchuk, Rancho Santa Fe, CA (US);

Assignees:

ASAVI LLC, Hallandale, FL (US);

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/57 (2006.01); A61P 31/14 (2006.01); A61K 31/427 (2006.01); A61K 31/403 (2006.01);
U.S. Cl.
CPC ...
A61K 38/57 (2013.01); A61K 31/403 (2013.01); A61K 31/427 (2013.01); A61P 31/14 (2018.01);
Abstract

The present application relates to the new the pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including viral and bacterial pneumonia and COVID-19, using aprotinin (APR), ribavirin and/or nirmatrelvir (NIMR), the pharmaceutical kit and the pharmaceutical composition for this pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including COVID-19.


Find Patent Forward Citations

Loading…